Overview
- 72 inspections across 52 sites are on record.
- 179 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2015-05-29.
At a glance
Inspections
72
Sites
52
Observations
179
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| NIH Clinical Center Pharmacy Department | 29 May 2015 | Human Drugs | View 483 → |
| Amphastar France Pharmaceuticals | 7 Feb 2013 | Human Drugs | On file |
| Coty Lancaster SAM | 1 Feb 2013 | On file | |
| Barr Laboratories Inc. | 26 Jul 2012 | ||
| Mylan Pharmaceuticals Inc | 2 Feb 2012 | View 483 → |
Sites inspected
NIH Clinical Center Pharmacy DepartmentBethesda, United States1 insp.
Amphastar France PharmaceuticalsEragny Sur Epte, France1 insp.
Coty Lancaster SAMMonaco, Monaco1 insp.
Barr Laboratories Inc.Forest, United States1 insp.
Mylan Pharmaceuticals IncMorgantown, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Brooke K Higgins17 shared
Rachel C Harrington9 shared
Nebil A Oumer3 shared
Monique-Rac Lester3 shared
Merideth K Rose3 shared
William A Warnick2 shared
Latoya S Oliver-Powell2 shared
Stacey A Priest2 shared
Brian R Yaun2 shared
Daniel R Azar2 shared
Full investigator report
Get the verbatim findings behind Ernest Bizjak's 179 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site